Depletion of SIRT6 causes cellular senescence, DNA damage, and telomere dysfunction in human chondrocytes  by Nagai, K. et al.
Osteoarthritis and Cartilage 23 (2015) 1412e1420Depletion of SIRT6 causes cellular senescence, DNA damage,
and telomere dysfunction in human chondrocytes
K. Nagai, T. Matsushita*, T. Matsuzaki, K. Takayama, T. Matsumoto, R. Kuroda, M. Kurosaka
Department of Orthopaedic Surgery, Kobe University Graduate School of Medicine, 7-5-1, Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japana r t i c l e i n f o
Article history:
Received 20 June 2014
Accepted 18 March 2015
Keywords:
Sirtuin
SIRT6
Chondrocyte
Senescence
DNA damage
Telomere dysfunction* Address correspondence and reprint requests to:
Orthopaedic Surgery, Kobe University Graduate
Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan. Tel: 8
351-6944.
E-mail addresses: kant_kantona@yahoo.co.jp (K. N
(T. Matsushita), tokiomatsuzaki@yahoo.co.jp (T. Ma
gmail.com (K. Takayama), matsun@m4.dion.ne.jp (T.
kobe-u.ac.jp (R. Kuroda), kurosaka@med.kobe-u.ac.jp
http://dx.doi.org/10.1016/j.joca.2015.03.024
1063-4584/© 2015 Osteoarthritis Research Society Ins u m m a r y
Objective: SIRT6, a member of the sirtuin family of nicotinamide adenine dinucleotide (NADþ)-depen-
dent protein deacetylases, has been implicated as a key factor in aging-related diseases. However, the
role of SIRT6 in chondrocytes has not been fully explored. The purpose of this study was to examine the
role of SIRT6 in human chondrocytes by inhibiting SIRT6 in vitro.
Design: First, the localization of SIRT6 and proliferation cell nuclear antigen (PCNA) in human cartilages
was examined by immunohistochemistry. Next, SIRT6 was depleted by RNA interference (RNAi), and the
effect of SIRT6 depletion on changes in gene expression, protein levels, proliferation, and senescence in
human chondrocytes was assessed. Furthermore, to detect DNA damage and telomere dysfunction,
gH2AX foci and telomere dysfunction-induced foci (TIFs) were examined using immunoﬂuorescence
microscopy. The protein levels of two mediators for DNA damage induced-senescence, p16 and p21, were
examined by western blotting.
Results: Immunohistochemical analysis showed SIRT6 was preferentially expressed in the superﬁcial
zone chondrocytes and PCNA-positive cluster-forming chondrocytes in the osteoarthritic cartilage tissue
samples. Real-time PCR analysis showed that matrix metalloproteinase 1 (MMP-1) and MMP-13 mRNA
were signiﬁcantly increased by SIRT6 inhibition. Moreover, SIRT6 inhibition signiﬁcantly reduced pro-
liferation and increased senescence associated b-galactosidase (SA-b-Gal)-positive chondrocytes; it also
led to increased p16 levels. Immunoﬂuorescence microscopy showed that gH2AX foci and TIFs were
increased by SIRT6 inhibition.
Conclusion: Depletion of SIRT6 in human chondrocytes caused increased DNA damage and telomere
dysfunction, and subsequent premature senescence. These ﬁndings suggest that SIRT6 plays an impor-
tant role in the regulation of senescence of human chondrocytes.
© 2015 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Osteoarthritis (OA), a joint disease that often affects aged
individuals, develops in association with articular cartilage
degeneration. Multiple factors contribute to the development of
OA, including hereditary predisposition, mechanical stress, and
aging1,2. A number of pathological changes are observed during OAT. Matsushita, Department of
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ternational. Published by Elsevier Ldevelopment, including an imbalance between anabolic and cata-
bolic activity of chondrocytes, increased production of cartilage-
degrading enzymes such as matrix metalloproteinases (MMPs)
and a disintegrin and metalloproteinase with thrombospondin
motifs (ADAMTS)3,4, and increased apoptosis5,6 and senescence.
Recent studies have suggested that chondrocyte senescence plays
an important role in the pathogenesis and development of OA7,8.
Sirtuins are nicotinamide adenine dinucleotide (NADþ)-depen-
dent histone and non-histone protein deacetylases with an evolu-
tionarily conserved catalytic domain and mammalian homologs of
the yeast silent information regulator 2 (Sir2)9. Mammals have
seven sirtuins (SIRT1eSIRT7), which localize and translocate to
different cellular compartments and regulate the function of a wide
variety of protein substrates10,11. Recently, sirtuins have garnered
considerable research attention owing to the variety of roles they
play in aging-related diseases. Among the sirtuins, SIRT1 has beentd. All rights reserved.
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studies have shown that SIRT1 inhibits apoptosis of in vitro human
chondrocytes12, and its inhibition in human chondrocytes leads to
changes in the expression of OA-related genes13. Furthermore, loss
of SIRT1 in chondrocytes accelerate the development of OA in
mice14. Other studies have also shown that SIRT1 promotes
cartilage-speciﬁc gene expression15, and its overexpression in hu-
man chondrocytes inhibits changes in osteoarthritic gene expres-
sion induced by interleukin-1b16; these ﬁndings highlight the
important roles of SIRT1 in chondrocytes and OA. On the other
hand, SIRT6 has been recently implicated in DNA repair17e19, telo-
mere maintenance20, attenuation of inﬂammation21, and glucose
homeostasis22. Notably, studies in mice have shown that SIRT6
deﬁciency produces premature aging phenotypes17, whereas SIRT6
overexpression causes a moderate increase in the lifespan of male
mice23, strongly suggesting an important role of SIRT6 in aging and
aging-associated diseases. However, its role in chondrocytes and
OA has not been fully explored. The purpose of this study was to
determine SIRT6 expression levels in human chondrocytes and to
examine the role of SIRT6 in human chondrocytes by inhibiting
SIRT6 with an RNA interference (RNAi) technique. The hypothesis
was that SIRT6 exhibits protective functions toward human
chondrocytes.
Materials and methods
OA and non-OA cartilage sampling and processing
OA cartilage tissues were obtained from femoral condyles of six
different patients with varus knee OA during total knee arthro-
plasty. The cartilage samples were obtained from the distal part of
both the lateral femoral condyles (LFCs) and medial femoral con-
dyles (MFCs) of the knee joint. Lateral condyles and medial con-
dyles were used as cartilage with mild OA and cartilage with severe
OA, respectively. Articular cartilage tissues without OA were ob-
tained from six different patients undergoing surgery for femoral
neck fracture. None of the six patients had a history of joint disease,
and none of the samples from these six patients showed macro-
scopically obvious progressed OA changes.
All OA and non-OA cartilage samples were obtained in accor-
dance with the World Medical Association Declaration of Helsinki
ethical principles for medical research involving human subjects.
Histological analysis
Cartilage tissues were ﬁxed in 4% paraformaldehyde in 0.1 M
phosphate buffered saline (PBS) for 24 h, decalciﬁed for 2 weeks
with 10% ethylenediaminetetraacetic acid (EDTA), and then
embedded in parafﬁn wax. Each specimen was cut into 5-mm-thick
slices along the sagittal plane.
For safranin-O and fast green staining, sections were stained
with hematoxylin for 10 min, followed by fast green staining for
5 min and safranin-O staining for 5 min. For immunohistochem-
istry, deparafﬁnized sections were treated with 3% hydrogen
peroxide to block endogenous peroxidase activity. Heat-induced
epitope retrieval was performed in a citrate buffer for 20 min at
95C. The sections were incubated with primary antibody over-
night at 4C. Following this, sections were incubated with horse-
radish peroxidase (HRP)-conjugated goat anti-rabbit IgG polyclonal
antibody (Nichirei Bioscience, Tokyo, Japan) for 30 min at room
temperature.
The signal was developed as a brown reaction product by using
the peroxidase substrate 3,30-diaminobenzidine (Nichirei Biosci-
ence) with methyl green counterstaining, and the sections were
microscopically examined. To detect SIRT6, rabbit anti-humanSIRT6 antibody (Abcam) was used at a 1:100 dilution. Further-
more, to address proliferative activity of chondrocytes in human
cartilage, immunostaining for proliferation cell nuclear antigen
(PCNA) was performed using rabbit anti-human PCNA antibody
(Abcam) at a 1:100 dilution.
Culture of human chondrocytes
Normal human knee articular chondrocytes (NHAC-kn; Lonza
Walkersville, Walkersville, MD) were purchased and maintained
with the Chondrocyte Growth Medium (Lonza) according to the
supplier's protocol. These are human primary chondrocytes iso-
lated from donor knee joints without any abnormalities. Each
donor is assigned to one lot number and NHAC-kn of three different
lot numbers was used in this study. We conﬁrmed that these cells
preserved the characteristic phenotype of normal chondrocytes, as
we and others have previously reported12,13,16,24,25. Chondrocytes
between passages three and six were used for the study.
Detection of the localization of SIRT6 in normal human
chondrocytes
To detect the localization of SIRT6 in chondrocytes, immuno-
cytochemistrywas performed. Brieﬂy, normal human chondrocytes
from three donors (passage 3) were seeded onto a slide clip, and
cultured for 24 h at 37C in an incubator under 20% O2/5% CO2.
Then, the chondrocytes were ﬁxed with 4% paraformaldehyde in
PBS for 10 min, followed by permeabilization with 0.25% Triton X-
100 in PBS for another 10 min. The cells were subsequently washed
with PBS, blocked with 1% bovine serum albumin (BSA) (Sigma-
eAldrich) in PBS containing 0.1% Tween-20 for 1 h, and incubated
with an anti-SIRT6 rabbit polyclonal (Abcam) at a 1:200 dilution for
1 h, followed by Alexa Fluor 594-conjugated goat anti-rabbit IgG
(Invitrogen) at a 1:5000 dilution. After antibody staining, the cover
slips were washed extensively in PBS and nuclei were counter-
stained with DAPI, followed by mounting as described above.
Samples were viewed with a BZ-X700 (Keyence, Japan) microscope
equipped with 40 objective lens and ﬂuorescence ﬁlter sets
appropriate for DAPI and Texas Red.
SIRT6 inhibition
Normal human chondrocytes from three donors (n ¼ 3, passage
from 3 to 6) were transfected with 100 pmol small interfering RNA
(siRNA) for human SIRT6 or control non-silencing siRNA. The sense
strand sequences of the RNA duplexes for human SIRT6 were as
follows: No 1, 50-CUGUCCAUCACGCUGGGUATT-30 and No. 2, 50-
CUCACUUUGUUACUUGUUUTT-30 (SigmaeAldrich, Saint-Louis,
Missouri, USA). Cells were seeded on a six-well plate (1.5  105/
well) and transfected using Lipofectamine 2000 transfection re-
agent (Invitrogen, Carlsbad, CA, USA) according to the manufac-
turer's protocol. RNA or proteins were extracted 48 h after
transfection.
RNA isolation and quantitative real-time PCR analysis
RNA was extracted with QIAshredder homogenizers and the
RNeasy Mini kit (Qiagen, Valencia, CA, USA) according to the
manufacturer's protocol, and ﬁrst-strand complementary DNA
(cDNA) was transcribed using High-Capacity cDNA Reverse
Transcription Kit (Applied Biosystems). The converted cDNA
samples (2 mL) were ampliﬁed in duplicate by quantitative real-
time RT-PCR (ABI Prism 7700 Sequence Detection System) in a
ﬁnal volume of 25 mL using SYBR Green Master Mix reagent
(Applied Biosystems).
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MMP-9,MMP-13, and GAPDHwere obtained from Takara Bio (Shiga,
Japan; Table I).
Melting curve analysis was performed using Dissociation Curves
software (Applied Biosystems) to ensure that only a single product
was ampliﬁed. Results were obtained using ABI Prism 7700
sequence detection software and evaluated using Excel (Microsoft,
Redmond, WA, USA). The values were normalized with those for
GAPDH, and relative expression was analyzed using the DDCt
method. The value for control siRNA expression level/GAPDH was
set as 1.
RT-PCR analysis
The cDNA samples were ampliﬁed by RT-PCR in ﬁnal volume of
40 ml using Ampli Taq Gold® DNA Polymerase with Gene Amp 10
PCR Buffer II and MgCl2 Solution/dNTP (Applied Biosystems). The
conditions for the PCR thermal cycling were as follows: 45 cycles of
denaturation at 94C for 30 s, annealing at 58C for 30 s, and a ﬁnal
extension at 72C for 60 s. The ﬁnal PCR products of 20 ml were
electrophoresed on a 2% agarose gel, and visualized with a LAS-
3000 mini (Fujiﬁlm, Tokyo, Japan). The primers for COL2A1,
COL1A1, and b-Actin were obtained from Takara Bio (Shiga, Japan,
Supplemental Table 1).
Protein isolation and western blotting analysis
After lipofection, normal human chondrocytes from three do-
nors (passage 3 and 4) were lysed, and proteinswere extractedwith
whole cell lysis buffer (Mammalian Protein Extraction Reagent,
Thermo Scientiﬁc, Rockford, IL, USA) supplementedwith proteinase
and phosphatase inhibitor mix (Thermo Scientiﬁc) according to the
manufacturer's protocol. The lysates were centrifuged at
15,000 revolutions per minute for 15 min to remove cellular debris,
and the supernatants were collected.
Separated proteins were electrotransblotted onto the blotting
Polyvinylidene Diﬂuoride (PVDF) membrane (Hybond-P, GE
Healthcare) with sodium dodecyl sulfateepolyacrylamide gel
electrophoresis (SDS-PAGE). The membranes were probed with
primary antibodies followed by an HRP-conjugated secondary
antibody. Proteins were visualized with ECL Plus reagent (GE
Healthcare) with a Chemilumino analyzer LAS-3000 mini (Fuji-
ﬁlm, Tokyo, Japan). Membranes were reprobed with anti-human
a-tubulin antibody (SigmaeAldrich) to conﬁrm equal protein
loading.
The following antibodies were used in this study: rabbit anti-
human SIRT6 antibody, rabbit anti-human p21 antibody (both
from Cell Signaling Technology), and mouse anti-human p16
antibody (Santa Cruz); and HRP-conjugated goat anti-rabbit IgG
and HRP-conjugated goat anti-mouse IgG (both from GE
Healthcare).Table I
Primer sequences for real-time PCR analysis
Target
gene
Primer sequences (50-30)
Forward Reverse
SIRT6 CTGGTCAGCCAGAACGTGGA CACGACTGTGTCTCGGACGTA
MMP-1 CTGGCCACCACTGCCAAATG CTGTCCCTGAACAGCCCAGTACTTA
MMP-2 CTCATCGCAGATGCCTGGAA CAGCCTAGCCAGTCGGATTTG
MMP-3 ATTCCATGGAGCCAGGCTTTC CATTTGGGTCAAACTCCAACTGTG
MMP-9 ACGCACGACGTCTTCCAGTA CCACCTGGTTCAACTCACTCC
MMP-13 TTGATGATGATGAAACCTGGACAAG TTGCCGGTGTAGGTGTAGATAGGAA
GAPDH GCACCGTCAAGGCTGAGAA TGGTGAAGACGCCAGTGGACell proliferation assay
The proliferation activity of normal human chondrocytes in the
presence of SIRT6 siRNA and control siRNA was examined using a
Cell Counting Kit-8 (CCK-8; Dojindo Laboratories, Kumamoto,
Japan) according to the manufacturer's instructions. Brieﬂy, normal
human chondrocytes from three donors were seeded onto 96-well
culture plates at density of 5.0  103 cells per well and cultured for
24 h at 37C in an incubator under 20% O2/5% CO2. After the cells
had been cultured for 24 h, SIRT6 and control siRNA were trans-
fected by lipofection. CCK-8 solution was added into each well at 0,
24, 48, 72, and 96 h after lipofection respectively, and incubated for
1 h. Optical density was measured using a plate reader at 450 nm at
0, 24, 48, 72, and 96 h after lipofection (n ¼ 3, passage 3, 5 and 6).
Senescence associated b-galactosidase (SA-b-Gal) assay
Cytochemical staining for SA-b-Gal was performed using a SA-b-
Gal staining kit (#9860; Cell Signaling Technology). Brieﬂy, normal
human chondrocytes from three donors were seeded onto 6-well
culture plates at density of 1.0  105 cells per well and cultured
for 24 h at 37C in an incubator under 20% O2/5% CO2. After the cells
had been cultured for 24 h, SIRT6 and control siRNA were trans-
fected by lipofection according to the manufacturer's instructions.
Forty-eight hours after lipofection, cytochemical staining for SA-b-
Gal was performed at pH 6 according to the manufacturer's pro-
tocol, and the positive cells in four randomly selected ﬁelds per
treatment were counted (n ¼ 3, passage 3 and 6).
Detection of gH2AX foci and telomere dysfunction-induced foci
(TIFs)
TodetectDNAdamageand telomeredysfunction, thegH2AX foci,
which represents phosphorylated histone H2AX, and TIFs where
gH2AX foci co-localizedwith telomere repeat binding factor-1 (TRF-
1) were examined 48 h after lipofection using immunoﬂuorescence
confocal microscopy, as previously described26,27. In brief, normal
human chondrocytes from three donors (NHAC-kn,n¼ 3, passage 3)
were seeded onto cover slips and cultured for 24 h at 37C in an
incubator under 20%O2/5% CO2. After the cells had been cultured for
24 h, SIRT6 or control siRNA were transfected by lipofection ac-
cording to the manufacturer's instructions. Forty-eight hours after
lipofection, chondrocytes were ﬁxed for 10 min with 4% para-
formaldehyde in PBS, followed by permeabilization with 0.25%
Triton X-100 in PBS for 10min. The cells were subsequently washed
with PBS, blocked for 1 h with 1% BSA (SigmaeAldrich) in PBS con-
taining 0.1% Tween-20, and then incubated for 1 hwith an anti-TRF-
1 mouse monoclonal antibody (clone TRF-78, Abcam) at a 1:1000
dilution, followed by a goat anti-mouse IgG-Alexa Fluor 488 conju-
gate (Invitrogen) at a 1:1000 dilution. Before incubation with the
second primary antibody, the cells were thoroughly washed in PBS/
0.1% Tween-20, post-ﬁxed with 4% paraformaldehyde for 15 min,
washed againwith PBS, and then incubated for a further 15minwith
25 mM glycine in PBS to inactivate the paraformaldehyde.
gH2AX was detected by incubation with a rabbit polyclonal
antibody raised against a synthetic phosphopeptide mapping to
residues surrounding Ser139 of human histone H2A.X (Cell
Signaling) at a 1:100 dilution, followed by Alexa Fluor 594-
conjugated goat anti-rabbit IgG (Invitrogen) at a 1:5000 dilution.
After antibody staining, the cover slips were washed extensively in
PBS/0.1% Tween-20 and nuclei were counterstained with DAPI,
followed by mounting as described above.
Samples were viewed with a LSM700 (Zeiss, Germany) micro-
scope equipped with 40 objective lens and ﬂuorescence ﬁlter sets
as appropriate for viewing DAPI, ﬂuorescein, and Texas Red staining
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images were captured using the Zen software. Digital micropho-
tographs of 20 ﬁelds randomly selected from both chondrocytes
transfected with control siRNA and SIRT6 siRNAwere obtained, and
images of each chondrocyte were captured. The average area of
gH2AX foci per cell for each treatment was automatically calculated
using ImageJ software (http://rsbweb.nih.gov/ij/). In addition, the
number of TIFs per cell was counted manually and then averaged.
Twenty nuclei from the chondrocytes transfected with SIRT6 siRNA
and control siRNA were examined in each donor.
Statistical analysis
All data were expressed as the mean ± 95% conﬁdence interval
(95% CI). The results were analyzed using StatView 5.0 (Abacus
Concepts Inc., Berkeley, CA, USA). Comparisons between two
groups were made using t-test. The normality and homogeneity of
variance of data were tested before statistical analysis. When the
conditions for data properties were fulﬁlled, t-test was used. A P
value <0.05 was considered statistically signiﬁcant.
Results
SIRT6-positive chondrocytes were observed in human cartilage
samples and cultured human chondrocytes
Immunohistochemical analysis showed that SIRT6-positive
cells were present in normal cartilage, and in mild and severeFig. 1. SIRT6 expression in articular cartilages and cultured chondrocytes (A) Microscopic
bars ¼ 100 mm). Cartilage samples are MFC and LFC from a 72-year-old female patient with
fracture. The chondrocytes with brown-colored nucleus were positive. Representative result
and LFC. (B) A microscopic image of immunohistochemistry of the FH for SIRT6 taken at a h
Microscopic images of cultured human chondrocytes immunostained with antibodies again
(scale bars ¼ 20 mm). Immunoﬂuorescence analysis showed that SIRT6 was expressed in hu
from repeated experiment using human chondrocytes from three different donors.OA cartilage obtained from elderly patients [Fig. 1(A) and (B)].
SIRT6 expression was localized to the nucleus and mainly
expressed in the superﬁcial zone of articular cartilage. Repre-
sentative results were obtained from six different patients for FH
and six different OA patients for MFC and LFC. Immunoﬂuores-
cence analysis also showed that SIRT6 was expressed in human
chondrocytes and localized to the nucleus [Fig. 1(C)].
Depletion of SIRT6 induced up-regulation of MMP-1 and MMP-13
The SIRT6 mRNA level was signiﬁcantly reduced to approxi-
mately 40% by SIRT6 siRNA transfection (1 vs 0.41 ± 0.04, n ¼ 3,
P ¼ 0.001). The SIRT6 protein level was also markedly reduced by
SIRT6 siRNA, showing that SIRT6 was efﬁciently inhibited by
SIRT6 siRNA [Fig. 2(A)]. In the real-time PCR analysis, the deple-
tion of SIRT6 signiﬁcantly increased MMP-1 (1 vs 2.3 ± 0.5,
P ¼ 0.03) and MMP-13 mRNA expression (1 vs 4.7 ± 0.4, P ¼ 0.01),
but no signiﬁcant changes were observed in MMP-2 (1 vs 1.0 ± 0.1,
P ¼ 0.74), MMP-3 (1 vs 1.1 ± 0.1, P ¼ 0.15), or MMP-9 expression (1
vs 1.2 ± 0.3, P ¼ 0.30) [Fig. 2(C)]. Similar results were obtained
with a different sequence of siRNA for SIRT6 (Supplemental
Fig. 1(A), (B)).
Depletion of SIRT6 caused premature senescence and the decrease of
proliferation activity
Immunohistochemical analysis showed that SIRT6 was strongly
expressed in chondrocytes, forming clusters that also expressedimages of Safranin-O, Immunohistochemistry for SIRT6 and negative control (scale
varus OA, and femoral head (FH) from a 74-year-old female patient with femoral neck
s were obtained from six different patients for FH and six different OA patients for MFC
igh magniﬁcation (400). SIRT6 was localized to the nucleus (Scale bar ¼ 100 mm). (C)
st SIRT6 (red) counterstained with DAPI (blue), and merged images of DAPI and SIRT6
man chondrocytes and localized to the nucleus. Representative results were obtained
Fig. 2. The efﬁciency and inﬂuence of SIRT6 inhibition by SIRT6 siRNA (A) Real-time PCR analysis for SIRT6 mRNA in normal human chondrocytes. The SIRT6 mRNA level was
signiﬁcantly reduced to approximately 40% by SIRT6 siRNA transfection. Non-silencing siRNAwas used as a control. *Statistically signiﬁcant difference (n ¼ 3, P ¼ 0.001). GAPDH was
used as endogenous control. The value for control expression level/GAPDH was set as 1. Values are the mean ± 95% CI. (B) Western blotting analysis for SIRT6 in normal human
chondrocytes. Tubulin was served as a control. Representative results are shown from three different donors. (C) Real-time PCR analysis for the expression of MMP family members.
MMP-1 and 13mRNAwere signiﬁcantly increased by the SIRT6 depletion. GAPDH was used as endogenous control. The value for control siRNA expression level/GAPDH was set as 1.
Values are the mean ± 95% CI. *Statistically signiﬁcant difference (n ¼ 3, P ¼ 0.03 and P ¼ 0.01 respectively).
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suggests a role of SIRT6 in chondrocyte proliferation, which we
proceeded to investigate.
The proliferation assay showed that the absorbance of the siRNA
group was signiﬁcantly lower than that of controls at 72 and 96 h
after lipofection (0.77 ± 0.06 vs 0.99 ± 0.06, P¼ 0.02 and 1.16 ± 0.11
vs1.53 ± 0.10, P ¼ 0.002, respectively. n ¼ 3), [Fig. 3(B)], indicating
that proliferation was reduced when SIRT6 was depleted. Further-
more, the SA-b-Gal assay showed that the percentage of SA-b-Gal-
positive cells was signiﬁcantly higher in the SIRT6 siRNA group
(24.3 ± 4.2%) than in the control group (11.3 ± 3.0%) (n ¼ 3,
P ¼ 0.008; Fig. 3(C)), indicating that the depletion of SIRT6 induced
premature senescence.
Depletion of SIRT6 caused accumulation of gH2AX foci and TIFs
To elucidate the mechanism by which depletion of SIRT6 re-
duces proliferation and induces premature senescence, we exam-
ined whether depletion of SIRT6 results in the accumulation of
gH2AX foci and TIFs, which form at sites of DNA damage and
dysfunctional telomeres. Immunoﬂuorescence microscopic ana-
lyses showed that gH2AX foci and TIFs were increased in the SIRT6-
depleted chondrocytes than in controls [Fig. 4(A)]. The relative area
of gH2AX was signiﬁcantly greater in the SIRT6-depleted chon-
drocytes (1.9 ± 0.1/cell) than in control chondrocytes (1.0 ± 0.1/cell)
(n ¼ 3, P ¼ 0.0001; Fig. 4(B)). In addition, the average number of
TIFs per cell was signiﬁcantly higher in the SIRT6-depletedchondrocytes (3.5 ± 0.8/cell) than in control chondrocytes
(1.3 ± 0.2/cell) (n ¼ 3, P ¼ 0.007; Fig. 4(C)).
Depletion of SIRT6 up-regulated p16, but not p21
To examine the downstream signaling pathways that mediate
the induction of senescence by SIRT6 depletion, we used western
blotting to assess the protein levels of mediators for DNA damage-
induced senescence, cyclin-dependent kinase inhibitors (CDKIs)
p16 and p21. The p16 protein level was higher and p21 protein level
was lower in the SIRT6-depleted chondrocytes than those in con-
trol chondrocytes (Fig. 5). Results are representative of experiments
performed using three different donors.
Discussion
To the best of our knowledge, this is the ﬁrst study to showa role
of SIRT6 in human chondrocytes. In the ﬁrst step of the study, SIRT6
expression in human chondrocytes was conﬁrmed by immuno-
histochemistry. SIRT6 was localized to the nucleus in human
chondrocytes, similar to that previously reported by Michishita
et al.who showed the localization of SIRT6 to the nucleus in normal
human ﬁbroblast28. Additionally, SIRT6 was mainly expressed in
the superﬁcial zone of cartilage, where chondrocytes are directly
under stress. SIRT6 was also strongly expressed in the PCNA-
positive chondrocytes that form clusters in OA cartilage. Forma-
tion of clusters is a characteristic feature observed during
Fig. 3. The inﬂuence of the depletion of SIRT6 on proliferation and senescence. (A) The expression of SIRT6 and PCNA in articular cartilage of MFC from a 72-year-old female patient
with varus OA. Safranin-O, Immunohistochemistry for SIRT6 at 40 and 100, and for PCNA at 100. SIRT6 was strongly expressed in chondrocytes forming clusters that also
express PCNA. (Scale bars ¼ 100 mm). Representative results are shown from six repeated experiments from six different patients. (B) Proliferation activity assay using Cell Counting
Kit-8. Depletion of SIRT6 signiﬁcantly reduced proliferation activity 72 and 96 h after lipofection. Values are the mean ± 95% CI of the data obtained from three donors. *Statistically
signiﬁcant difference (n ¼ 3, P ¼ 0.02 and P ¼ 0.002 respectively). (C) SA-b-Gal assay. The percentage of SA-b-Gal positive cells was signiﬁcantly higher in the SIRT6 siRNA group
compared with the control group. Values are the mean ± 95% CI of the data obtained from three donors. (Scale bar ¼ 100 mm). *Statistically signiﬁcant difference (n ¼ 3, P ¼ 0.008).
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proliferating clonal chondrocytes29. It has been suggested this is a
self-reparatory process30, which implies that SIRT6 plays a role in
the proliferation of chondrocytes.
As a second step, we examined the effects of inhibiting SIRT6 in
human chondrocytes in vitro to elucidate the role of SIRT6. Inhibi-
tion of SIRT6 reduced proliferation of human chondrocytes.
Recently, Piao et al. reported that the thickness of the proliferating
zone and the hypertrophic zone of the growth plate is reduced in
Sirt6-deﬁcient mice31 and that inhibition of Sirt6 reduces expres-
sion of cyclin D1 and D2, and Indian hedgehog signaling in mouse
epiphyseal chondrocytes. These reports support the idea that SIRT6
is an important regulator for chondrocyte proliferation.
Inhibition of SIRT6 also increased senescence of chondrocytes.
Similar protective roles of SIRT6 have been reported in other
types of cells such as endothelial cells27, induced pluripotent
stem cells32, and ﬁbroblasts33, although the descriptions of the
underlying mechanisms of the regulation of senescence by SIRT6
differ. We observed that depletion of SIRT6 led to accumulation
of DNA damage and telomere dysfunction, as detected by
increased gH2AX-positive areas and TIFs. These observations
suggest that increased DNA damage and telomere dysfunction
resulted in subsequent DNA damage responses and eventual
cellular senescence. In support of this idea, several studies have
described the mechanisms through which SIRT6 promotes DNA
repair and protects from telomere dysfunction. SIRT6 contributes
to DNA double-strand break repair by controlling mobilization of
a DNA double-strand break repair factor18 or by interacting with
poly[ADPeribose] polymerase 119 in response to DNA damage. In
addition, SIRT6 prevents telomere dysfunction through deacety-
lation at telomeres20. These ﬁndings, together with ourobservations, suggest that SIRT6 prevents premature senescence
of human chondrocytes by controlling DNA repair and main-
taining proper telomere function.
Two cell-cycle inhibitors that are often expressed by senescent
cells are the CDKIs p21 and p1634e36. These CDKIs are components
of tumor-suppressor pathways that are governed by the p53 and
retinoblastoma (pRB) proteins, respectively. Both the p21 pathway
and the p16 pathway can establish and maintain growth arrest,
which is a typical feature of cellular senescence37. DNA damage is
one of the many stimuli that induce senescence, and DNA-damage
initiated senescence depends on p53 and is usually accompanied by
the expression of p2126,38. However, in many types of cells, DNA
damage and telomere dysfunction also induce p16, which provides
a second barrier to block cell growthwith severely damaged DNA or
dysfunctional telomeres39e41. This is an essential role in prevention
of senescence.
The relationship between p16 and OAwas revealed in a study by
Zhou et al.42 who reported that p16-positive cells aremore plentiful
in OA chondrocytes than in age-matched normal tissue. In addition,
siRNA knockdown of p16 in OA chondrocytes decreases senescent
features while promoting proliferation of chondrocytes and matrix
gene expression42. This ﬁnding indicates that p16 is involved in the
pathogenesis of OA. In the present study, the p16 protein level was
increased by the SIRT6 depletion, but the p21 protein level was not,
which suggests that SIRT6 protects human chondrocytes from
senescence via the p16-pRB pathway. It is intriguing that the level
of p16 was increased whereas that of another senescence regulator,
p21, was decreased in the senescent cells. Stein et al.41 showed a
differential role of CDK inhibitors p21 and p16 in the regulation of
senescence and differentiation in human ﬁbroblasts. They observed
that p21 was up-regulated during the early stage of senescence,
Fig. 4. The inﬂuence of the depletion of SIRT6 on DNA damage and telomere dysfunction. (A) Microscopic images of control siRNA and SIRT6 siRNA chondrocytes immunostained
with antibodies against gH2AX (red) and TRF-1 (green), and counterstained with DAPI (blue). White arrows in the merged images point to sites of co-localization which means TIFs.
Scale bars ¼ 5 mm gH2AX foci and TIFs were increased in the SIRT6-depleted chondrocytes than in controls. Representative results are shown from four repeated experiments using
chondrocytes from three different donors. (B) Quantiﬁcation of gH2AX foci expressed as mean relative area per cell. Twenty nuclei from the chondrocytes transfected with SIRT6
siRNA and control siRNA were examined. The relative area of gH2AX foci was signiﬁcantly greater in the SIRT6-depleted chondrocytes than in control chondrocytes. Values are the
mean ± 95% CI. *Statistically signiﬁcant difference (n ¼ 3, P ¼ 0.0001). (C) Quantiﬁcation of TIFs per cell. Twenty nuclei from the chondrocytes transfected with SIRT6 siRNA and
control siRNA were examined in each donor. The average number of TIFs per cell was signiﬁcantly higher in the SIRT6-depleted chondrocytes than in control chondrocytes. Values
are the mean ± 95% CI. *Statistically signiﬁcant difference (n ¼ 3, P ¼ 0.007).
K. Nagai et al. / Osteoarthritis and Cartilage 23 (2015) 1412e14201418whereas once senescence was achieved, p21 decreased and p16
increased. Thus, they concluded that the up-regulation of p16
might be essential for maintenance of the senescent cell-cycle ar-
rest. Thus, we speculate that senescence might have been alreadyFig. 5. Western blotting for p16 and p21. The p16 protein level was higher and the p21
protein level was lower in the SIRT6-depleted chondrocytes than in control chon-
drocytes. Representative results were obtained from three different donors. Tubulin
was used as a control.achieved at the time of the extraction of protein, causing the
discrepancy between the levels of p16 and p21 in SIRT6-deﬁcient
chondrocytes in the present study.
We also observed increased expression of MMP-1 and MMP-13
mRNA associated with inhibition of SIRT6. MMP-1 and MMP-13 are
classic collagenases. In particular, MMP-13 is a major mediator of
type 2 collagen cleavage, and signiﬁcant roles for MMP-13 in the
development of OA have been suggested43e46. In addition, it has
been reported that immunostaining for MMP-1 and MMP-13 in
cartilage is increased in association with aging47. The regulatory
mechanism underlying MMP-1 and MMP-13 expression is
intriguing. SIRT6 is known to regulate the nuclear factor kappaB
(NF-kB) pathway, a major mediator for inﬂammatory responses.
Therefore, it is possible that MMP-1 and MMP-13 expression were
increased through the regulation of NF-kB21. Furthermore, cells
undergoing a senescent process often exhibit characteristic
phenotypic changes such as increased MMPs and interleukins8,
referred to as the senescent secretory phenotype36,37. Therefore, it
is also possible that the increasedMMP-1 andMMP-13 expression is
associated with phenotypic changes of the SIRT6-depleted chon-
drocytes to the senescent secretory phenotype. Further studies are
required to elucidate the mechanism of the regulation of MMP-1
and MMP-13 by SIRT6.
K. Nagai et al. / Osteoarthritis and Cartilage 23 (2015) 1412e1420 1419It should be noted that current our study has a limitation.
Although human chondrocytes extracted fromhealthy donors were
used for the experiments in vitro, the chondrocytes were partially
de-differentiated and ﬁbroblastic as RT-PCR analysis showed a
decreased COL2A1/COL1A1 ratio (Supplemental Fig. 2). Therefore,
our results may be limited to chondrocytes that show some level of
de-differentiation. However, considering one of the characteristic
observations during progression of OA that chondrocytes become
ﬁbroblastic, we believe that our study provides insight into the role
of SIRT6 in the regulation of human chondrocyte senescence and
pathogenesis of OA despite this limitation.
In conclusion, we demonstrated that depletion of SIRT6 in hu-
man chondrocytes decreased proliferation while inducing prema-
ture senescence. In addition, depletion of SIRT6 led to accumulation
of DNA damage and telomere dysfunction. Our observations sug-
gest that SIRT6 plays an important role in protecting chondrocytes
from premature senescence, DNA damage, and telomere dysfunc-
tion. Further studies of the role of SIRT6 in senescence of human
chondrocytes may help elucidate the pathogenesis of OA, and
conﬁrm the potential of SIRT6 as a new therapeutic target for OA.
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